Fardman, A., Kodesh, A., Siegel, A. J., Segev, A., Regev, E., Maor, E., . . . Grupper, A. (2024). The safety of sodium glucose transporter 2 inhibitors and trends in clinical and hemodynamic parameters in patients with left ventricular assist devices. Artificial Organs, 48(8), 902. https://doi.org/10.1111/aor.14733
Chicago Style (17th ed.) CitationFardman, Alexander, et al. "The Safety of Sodium Glucose Transporter 2 Inhibitors and Trends in Clinical and Hemodynamic Parameters in Patients with Left Ventricular Assist Devices." Artificial Organs 48, no. 8 (2024): 902. https://doi.org/10.1111/aor.14733.
MLA (9th ed.) CitationFardman, Alexander, et al. "The Safety of Sodium Glucose Transporter 2 Inhibitors and Trends in Clinical and Hemodynamic Parameters in Patients with Left Ventricular Assist Devices." Artificial Organs, vol. 48, no. 8, 2024, p. 902, https://doi.org/10.1111/aor.14733.